Skip to main content

Advertisement

SpringerLink
Log in

Modulation of Matrix Metalloproteinase Secretion by Adenosine A3 Receptor in Preeclamptic Villous Explants

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

The impairment of trophoblast invasion associated with preeclampsia may involve matrix metalloproteinase (MMP). Adenosine A3 receptors expression in trophoblast is upregulated in preeclampsia. This study was designed to determine if A3 receptors modulate MMP secretion in villous explants from preeclamptic pregnancies. Villous explants from normal and preeclamptic pregnancies were cultured at 20% and 3% oxygen. There were significantly increased A3 receptor and reduced MMP-2/-9 expression at low oxygen level in normal and preeclamptic explants. Interestingly, in preeclamptic explants, after high oxygen culture, the expression of MMP-2/-9 were recovered to almost same level of those in normal explants. Treatment of preeclamptic explants with A3 receptor agonist in low oxygen level resulted in an enhanced expression of MMP-2/-9 in a time- and dose-dependent manner. In summary, this study indicates that trophoblastic adenosine A3 receptors are 1) modulated by oxygen tension, and 2) regulate MMP-2/-9 expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens. 1991;4:700–708.

    Article  CAS  PubMed  Google Scholar 

  2. Khong TY, Robertson WB. Spiral artery disease. In: Coulam CB, Faulk WP, McIntyre JA, eds. Immunological Obstetrics. New York: W.W. Norton & Company; 1992: 492–501.

    Google Scholar 

  3. Fisher SJ, Leitch MS, Kantor MS, Basbaum CB, Kramer RH. Degradation of extracellular matrix by the trophoblastic cells of first-trimester human placentas. J Cell Biochem. 1985;27:31–41.

    Article  CAS  PubMed  Google Scholar 

  4. Bode W, Maskos K. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biol Chem. 2003;384:863–872.

    Article  CAS  PubMed  Google Scholar 

  5. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000;1477:267–283.

    Article  CAS  PubMed  Google Scholar 

  6. Pilcher BK, Wang M, Qin XJ, Parks WC, Senior RM, Welgus HG. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann NY Acad Sci. 1999;878:12–24.

    Article  CAS  PubMed  Google Scholar 

  7. Chin JR, Werb Z. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development. 1997;124:1519–1530.

    CAS  PubMed  Google Scholar 

  8. Heikinheimo K, Salo T. Expression of basement membrane type IV collagen and type IV collagenases (MMP-2 and MMP-9) in human fetal teeth. J Dent Res. 1995;74: 1226–1234.

    Article  CAS  PubMed  Google Scholar 

  9. Steffensen B, Hakkinen L, Larjava H. Proteolytic events of wound-healing—coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med. 2001;12:373–398.

    Article  CAS  PubMed  Google Scholar 

  10. Konttinen YT, Ainola M, Valleala H, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 1999;58:691–697.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001;44:585–594.

    Article  CAS  PubMed  Google Scholar 

  12. Huisman MA, Timmer A, Zeinstra M, et al. Matrixmetalloproteinase activity in first trimester placental bed biopsies in further complicated and uncomplicated pregnancies. Placenta. 2004;25:253–258.

    Article  CAS  PubMed  Google Scholar 

  13. Fernandez PL, Merino MJ, Nogales FF, Charonis AS, Stetler-Stevenson W, Liotta L. Immunohistochemical profile of basement membrane proteins and 72 kilo dalton type IV collagenase in the implantation placental site. An integrated view. Lab Invest. 1992;66:572–579.

    CAS  PubMed  Google Scholar 

  14. Huppertz B, Kertschanska S, Demir AY, Frank HG, Kaufmann P. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res. 1998;291:133–148.

    Article  CAS  PubMed  Google Scholar 

  15. Shimonovitz S, Hurwitz A, Dushnik M, Anteby E, Geva-Eldar T, Yagel S. Developmental regulation of the expression of 72 and 92 kD type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol. 1994;171:832–838.

    Article  CAS  PubMed  Google Scholar 

  16. Merchant SJ, Crocker IP, Baker PN, Tansinda D, Davidge ST, Guilbert LJ. Matrix metalloproteinase release from placental explants of pregnancies complicated by intrauterine growth restriction. J Soc Gynecol Invest. 2004;11:97–103.

    Article  CAS  Google Scholar 

  17. Shearer TW, Crosson CE. Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2002;43:3016–3020.

    PubMed  Google Scholar 

  18. Ernens I, Rouy D, Velot E, Devaux Y, Wagner DR. Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP/PKA/Ca2+ pathway. Circ Res. 2006;99:590–597.

    Article  CAS  PubMed  Google Scholar 

  19. Kim YH, Cho NH, Hwang HS, Kwon JY, Kang MH, Park YW. Differential expression of adenosine receptors in normal and preeclamptic human placentas. Kor J Obstet Gynecol. 2007;50:726–734.

    Google Scholar 

  20. Miller RK, Genbacev O, Turner MA, Aplin JD, Caniggia I, Huppertz B. Human placental explants in culture: approaches and assessments. Placenta. 2005;26:439–448.

    Article  CAS  PubMed  Google Scholar 

  21. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab. 1997;82:1582–1588.

    CAS  PubMed  Google Scholar 

  22. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Diagnosis and management of preeclampsia and eclampsia. Int J Gynecol Obstet. 2002;77: 67–75 [ACOG practice bulletin].

  23. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37:240–249.

    Article  CAS  PubMed  Google Scholar 

  24. Dano K, Behrendt N, Hoyer-Hansen G, et al. Plasminogen activation and cancer. Thromb Haemost. 2005;93:676–681.

    Article  CAS  PubMed  Google Scholar 

  25. Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta. 2005;1755:37–69.

    PubMed  Google Scholar 

  26. Van Belle H, Goossens F, Wynants J. Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am J Physiol. 1987;252:H886–H893.

    PubMed  Google Scholar 

  27. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413–492.

    CAS  PubMed  Google Scholar 

  28. Blay J, White TD, Hoskin DW. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 1997;57:2602–2605.

    CAS  PubMed  Google Scholar 

  29. Gessi S, Cattabriga E, Avitabile A, et al. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res. 2004;10:5895–5901.

    Article  CAS  PubMed  Google Scholar 

  30. Madi L, Ochaion A, Rath-Wolfson L, et al. The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res. 2004;10:4472–4479.

    Article  CAS  PubMed  Google Scholar 

  31. Rajakumar A, Whitelock KA, Weissfeld LA, Daftary AR, Markovic N, Conrad KP. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod. 2001;64:499–506.

    Article  CAS  PubMed  Google Scholar 

  32. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721–732.

    Article  CAS  PubMed  Google Scholar 

  33. Chen H-L, Yang Y, Hu X-L, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol. 1991;139:327–335.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Hu X-L, Yang Y, Hunt JS. Differential distribution of interleukin-1α and interleukin-1β proteins in human placentas. J Reprod Immunol. 1992;22:257–268.

    Article  CAS  PubMed  Google Scholar 

  35. Kameda T, Matsuzaki N, Sawai K, et al. Production of interleukin-6 by normal human trophoblast. Placenta. 1990;11:205–213.

    Article  CAS  PubMed  Google Scholar 

  36. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol. 1995;86:815–821.

    Article  CAS  PubMed  Google Scholar 

  37. Majka S, McGuire PG, Das A. Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:260–266.

    PubMed  Google Scholar 

  38. Eichler W, Friedrichs U, Thies A, Tratz C, Wiedemann P. Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Invest Ophthalmol Vis Sci. 2002;43:2767–2773.

    PubMed  Google Scholar 

  39. Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN. Adenosine A2a receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol. 2004;164: 1887–1892.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Feoktistov I, Ryzhov S, Zhong H, et al. Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension. 2004;44:649–654.

    Article  CAS  PubMed  Google Scholar 

  41. Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ Res. 2003;92: 485–492.

    Article  CAS  PubMed  Google Scholar 

  42. Merighi S, Benini A, Mirandola P, et al. Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells. Biochem Pharmacol. 2006;72:19–31.

    Article  CAS  PubMed  Google Scholar 

  43. Lockwood CJ, Oner C, Uz YH, et al. Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Bio Reprod. 2008;78:1064–1072.

    Article  CAS  Google Scholar 

  44. Almholt K, Johnsen M. Stromal cell involvement in cancer. Recent Results Cancer Res. 2003;162:31–43.

    Article  CAS  PubMed  Google Scholar 

  45. Pedersen TX, Pennington CJ, Almholt K, et al. Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. Carcinogenesis. 2005;26:1233–1240.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Yonsei University Health System, 134 Sinchon-dong, Seodaemun-gu, Seoul, Korea

    Young-Han Kim MD, PhD, Han-Sung Hwang MD, Young-Tae Kim MD, PhD & Yong-Won Park MD, PhD

  2. Department of Obstetrics and Gynecology, Ajou University College of Medicine, Suwon, South Korea

    Haeng-Soo Kim MD, PhD

Authors
  1. Young-Han Kim MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Han-Sung Hwang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Young-Tae Kim MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haeng-Soo Kim MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yong-Won Park MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yong-Won Park MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, YH., Hwang, HS., Kim, YT. et al. Modulation of Matrix Metalloproteinase Secretion by Adenosine A3 Receptor in Preeclamptic Villous Explants. Reprod. Sci. 15, 939–949 (2008). https://doi.org/10.1177/1933719108322431

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719108322431

Key words

Search

Navigation